Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on June 23, 2025
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
GlobeNewswire
·
June 23, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved a label …
USA Rare Earth Bolsters Global Sales Effort with Appointment of Ron Fogarty as Vice President of Sales
GlobeNewswire
·
June 23, 2025
STILLWATER, Okla., June 23, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the appointment of Ron Fogarty as Vice President of Sales. Mr. Fogarty will lead global sales efforts in support of the Company’ …
OXB completes acquisition of remaining stake in US subsidiary
GlobeNewswire
·
June 23, 2025
OXB completes acquisition of remaining stake in US subsidiary Progression to full ownership aligns with global strategy and supports long-term growth in the viral vector manufacturing market Oxford, UK – 23 June 2025: OXB (LSE: OXB) (“the Company”), a …
Changes in Nokia Corporation's own shares
GlobeNewswire
·
June 23, 2025
Nokia Corporation Stock Exchange Release 23 June 2025 at 14:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 113 390 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia …
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
GlobeNewswire
·
June 23, 2025
Nokia Oyj Pörssitiedote 23.6.2025 klo 14.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 113 390 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
June 23, 2025
WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor …
Sono-Tek Receives $1.12 Million Order from Global Medical Diagnostics Company for High-Volume Coating Platform
GlobeNewswire
·
June 23, 2025
MILTON, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), a leading developer of ultrasonic precision coating systems, today announced that it has received a $1.12 million order from a long-standing customer in the medical …
New DoseSpot Analysis of 100,000 GLP-1 Prescriptions Finds That Patients Overpaid by $10.2M Collectively
GlobeNewswire
·
June 23, 2025
BOSTON, June 23, 2025 (GLOBE NEWSWIRE) -- DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102,166 GLP-1 …
ATR Launches Free Logistics Program to Introduce Businesses to Cost-Effective, Secure ITAD Solutions in the Gulf Coast Region and Beyond
GlobeNewswire
·
June 23, 2025
PENSACOLA, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Advanced Technology Recycling (ATR), a national leader in IT asset disposition (ITAD) and R2v3/RIOS certified electronics recycling, is excited to launch a limited-time complimentary logistics program for …
Elevate Your Summer with Canada’s Leading Cannabis Brands and Products by Tilray Brands
GlobeNewswire
·
June 23, 2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, announces its 2025 summer cannabis …
Aya Gold & Silver Closes Credit Facility with the EBRD to Support Boumadine Development
GlobeNewswire
·
June 23, 2025
MONTREAL, June 23, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Company”) is pleased to announce the closing of the previously announced US$25 million credit facility with the European Bank for Reconstruction and …
FactSet Reports Results for Third Quarter 2025
GlobeNewswire
·
June 23, 2025
Q3 GAAP revenues of $585.5 million, up 5.9% from Q3 2024. Organic Q3 ASV of $2,296.9 million, up 4.5% year over year. Q3 GAAP operating margin of 33.2%, down approximately 350 bps year over year, and adjusted operating margin of 36.8%, down 270 bps year …
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
GlobeNewswire
·
June 23, 2025
PBFT02 continued to demonstrate robust, durable elevation in CSF PGRN levels and improvement in plasma NfL, a disease progression biomarker, compared to natural history Dose 2, 50% lower than Dose 1, substantially increased CSF PGRN levels at 30-days, …
Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
GlobeNewswire
·
June 23, 2025
Interactions with FDA over the past year have provided clear expectations for the path to submission of the nomlabofusp BLA Written FDA recommendations for safety database include a total of at least 30 participants with continuous exposure for 6 months …
Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depression (TRD) in Taiwan
GlobeNewswire
·
June 23, 2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced that it has out-licensed its biomarker-guided DB104 (liafensine) program to one of Taiwan’s …
Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
·
June 23, 2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the debut of …
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
GlobeNewswire
·
June 23, 2025
The study met its primary and all secondary efficacy endpoints for all dose groups Single doses of 450mg, 300mg and 150mg of CD388 conferred 76%, 61% and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo CD388 was …
AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB-268’s Efficacy in T Cell-Mediated Inflammatory Models
GlobeNewswire
·
June 23, 2025
ALTB-268 demonstrated therapeutic potential in murine models of colitis and GvHD, supporting its role as an immune checkpoint enhancer in T cell-mediated inflammatory diseases Findings reinforce ALTB-268’s ability to downregulate T cell effector function …
Sono Group N.V.’s CEO Shareholder Update – June 2025
GlobeNewswire
·
June 23, 2025
West Palm Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono Group” or “Sono”, parent company to Sono Motors GmbH or “Sono Motors”) today issued a shareholder update from …
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)
GlobeNewswire
·
June 23, 2025
In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with complete preservation of lean mass, outperforming the group given semaglutide alone Icovamenib …